Literature DB >> 9462230

Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis.

A Afeltra1, M Galeazzi, G D Sebastiani, G M Ferri, D Caccavo, M A Addessi, R Marcolongo, L Bonomo.   

Abstract

The aim of the present study was to evaluate the coexpression of very early (CD69), early (CD25) and late (HLADR) antigens and to analyse the mean fluorescence intensity (MFI) of such activation markers on synovial fluid (SF) and peripheral blood (PB) lymphocytes of patients affected by rheumatoid arthritis (RA) and other types of chronic synovitis (OCS). A three colour cytometric analysis was performed using a peridinin chlorophyll protein conjugated anti-CD3 antibody in combination with fluorescein isothiocyanate or phycoerythrin labelled anti-CD69, anti-HLADR, anti-CD25 monoclonal antibodies (mAbs). A T cell gating method was utilized, so that three sets of bivariant dot plot quadrant displays were obtained (CD69/HLADR, CD69/CD25, CD25/HLADR). A large percentage of SF T lymphocytes in RA showed the coexpression of very early and late activation antigens (CD3 + CD69 + HLADR +), whereas CD3 + CD69 + CD25 + bearing cells and CD3 + CD25 + HLADR + lymphocytes were only a small percentage. Similar results were obtained in patients with OCS, although to a lesser extent. No statistically significant differences in MFI of CD69 and HLADR positive SF T cells between RA and OCS were observed. The CD69 + CD25-HLADR + T cell subset is the most commonly represented in the synovial environment, among those we have evaluated; this phenotype may be characteristic of chronic inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462230      PMCID: PMC2694545          DOI: 10.1046/j.1365-2613.1997.290360.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  6 in total

1.  Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.

Authors:  B Berner; G Wolf; K M Hummel; G A Müller; M A Reuss-Borst
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4(+) T cells and disease activity.

Authors:  J Pawłowska; Z Smoleńska; A Daca; J M Witkowski; E Bryl
Journal:  Clin Exp Immunol       Date:  2010-12-13       Impact factor: 4.330

3.  Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes.

Authors:  Miguel Ascon; Dolores B Ascon; Manchang Liu; Chris Cheadle; Chaitali Sarkar; Lorraine Racusen; Heitham T Hassoun; Hamid Rabb
Journal:  Kidney Int       Date:  2008-12-17       Impact factor: 10.612

4.  The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.

Authors:  Balázs Szalay; Barna Vásárhelyi; Aron Cseh; Tivadar Tulassay; Magdolna Deák; László Kovács; Attila Balog
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

Review 5.  Is CD69 an effective brake to control inflammatory diseases?

Authors:  Roberto González-Amaro; José R Cortés; Francisco Sánchez-Madrid; Pilar Martín
Journal:  Trends Mol Med       Date:  2013-08-13       Impact factor: 11.951

6.  Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies.

Authors:  M J McCoy; R A Lake; R G van der Most; I M Dick; A K Nowak
Journal:  Br J Cancer       Date:  2012-08-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.